
Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency
Montag, 24. August 2026 · 30 min
Kapitelklicken springt direkt hin
Shownotes
Pink Sheet Editor-in-Chief Nielsen Hobbs, executive editor Derrick Gingery, and senior reporter Maaisha Osman discuss new FDA commissioner nominee Heidi Overton, her prospects for confirmation, and what her pick means for the agency.
More On The Topic From The Pink Sheet
FDA Commissioner Nominee Has The White House’s Trust. Winning Over Career Staff Is Another Matter: insights.citeline.com/pink-sheet/agency-leader…
Trump To Nominate White House Advisor Overton As FDA Commissioner: insights.citeline.com/pink-sheet/agency-leader…